Method of treating patients with a mucinous glycoprotein (MUC-1) vaccine

Details for Australian Patent Application No. 2006274651 (hide)

Owner Oncothyreon Inc.

Inventors Longenecker, B. Michael

Agent Davies Collison Cave

Pub. Number AU-B-2006274651

PCT Pub. Number WO2007/015171

Priority 60/694,233 28.06.05 US

Filing date 27 June 2006

Wipo publication date 8 February 2007

Acceptance publication date 27 September 2012

International Classifications

A61K 38/16 Medicinal preparations containing peptides - Peptides having more than 20 amino acids

A61K 9/127 Medicinal preparations characterised by special physical form - Liposomes

A61P 35/00 Antineoplastic agents

Event Publications

14 February 2008 PCT application entered the National Phase

  PCT publication WO2007/015171 Priority application(s): WO2007/015171

22 October 2009 Assignment before Grant

  Biomira, Inc. The application has been assigned to Oncothyreon Inc.

27 September 2012 Application Accepted

  Published as AU-B-2006274651

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006274653-Inflammation

2006274647-Reducing interference between oilcontaining adjuvants and surfactantcontaining antigens